Table 1: Baseline characteristics after the discontinuation of lenvatinib for HCC patients.

Characteristic	n=12
Mean age (years, range)	76.5 ±7.465 (67-86)
Sex (male/female)	6/6
Etiology (HBV/HCV/NBNC)	1/9/2
Child-Pugh score (5/6)	4/8
ALBI grade (1/2)	4/8
BCLC (B/C)	0/12
CONUT score (normal/mild/moderate/severe)	2/4/4/2
Portal vein tumor thrombosis (present/absent)	4/8
Extrahepatic spread (present/absent)	4/8
AFP (ng/mL)	140.72±56.58
DCP (mAU/mL)	448.20±210.36

HCC: Hepatocellular Carcinoma; HBV: Hepatitis B Virus; HCV: Hepatitis C Virus; NBNC: Non-HBV and Non-HCV; ALBI: Albumin-Bilirubin; BCLC: Barcelona Cancer Liver Clinic; CONUT: Controlling Nutritional Status; AFP: Alpha-Fetoprotein; DCP: Des-Gamma Carboxy-Prothrombin.